MOTS-c and Mitochondrial Peptides Explained Simply

1. What It's About

Mitochondria are the powerhouses of the cell. They have their own small genetic material, mitochondrial DNA. From it, short proteins called mitochondrial peptides are produced. The best-known of these is MOTS-c. These substances do not remain within the powerhouse but migrate out of it and act as signalling molecules throughout the body. In addition to MOTS-c, the group includes Humanin and SHLP1-6. MOTS-c is primarily produced during physical activity. Research into these substances has transformed the understanding of mitochondria. They are not merely energy suppliers but also influence cellular processes. These peptides are measured in the blood. This is challenging because they occur there only in very small quantities. Furthermore, their levels vary greatly between muscle, liver, brain, and blood. Therefore, a blood value provides only limited insight into what is happening in the body. A total of 410 studies were evaluated, including six controlled human trials.

2. What Studies Show

The most extensively studied aspect is how these peptides change following exercise. In a controlled trial involving 30 healthy individuals, Humanin levels in the blood increased significantly after 45 minutes of endurance training, while MOTS-c showed a rising trend. Resistance training produced no changes 2. A controlled trial with 95 people with mild to moderate Alzheimer's disease examined 16 weeks of training. Protective proteins in small vesicles released from nerve cells into the blood were measured. In the training group, these values increased, particularly in individuals with a specific genetic variant (APOE-ε4). Whether cognitive function improved was not assessed 1. Among 107 patients who underwent open-heart surgery with cardiopulmonary bypass, those with acute lung injury had lower MOTS-c levels in the blood. Cell experiments suggested that MOTS-c protects cells from stress. Whether this translates to humans remains untested 3. People with coronary endothelial dysfunction had lower MOTS-c levels, and these values correlated with the function of small blood vessels 5. In animal studies with mice, the addition of MOTS-c improved physical performance across all age groups. In humans, MOTS-c increased after exertion, but its effect on performance capacity in humans has not been examined 4. An observational study compared people with type 2 diabetes, people with Alzheimer's disease, and healthy older adults. In Alzheimer's disease, certain signalling molecules were lower, while in diabetes, another was elevated 6.

3. What Remains Unclear

Most studies identify associations rather than causation. For example, low MOTS-c levels occur alongside insulin resistance. Whether the peptide contributes to its development or is merely a marker remains uncertain. Controlled trials typically measure intermediate values such as blood sugar or inflammatory markers rather than disease progression or quality of life. Comparisons with established treatments are lacking. Whether externally administered MOTS-c produces the same effects in the body as endogenous MOTS-c is unknown. Long-term data on safety and tolerability are missing, as are studies on dosage and efficacy. Measurement methods vary, complicating comparisons. Differences between population groups, such as between Hispanic and non-Hispanic participants, are difficult to interpret methodologically 7.

4. What This Means in Everyday Life

Physical activity is the stimulus most consistently associated with higher levels of these peptides in studies. This is an observation, not a recommendation. A blood test for MOTS-c can be conducted, but it provides limited insight into its effects in the body due to the significant variation in tissue levels. For those interested in research, this is a young field: 410 studies evaluated, of which only six are controlled human trials. In everyday life, this means interpreting these findings as early indications rather than established effects. The next step would be to clarify whether administered peptides produce the same effects in humans as endogenous peptides and whether they influence disease progression.

All details with study numbers and sources: Detailed page on MOTS-c and mitochondrial peptides. For children: MOTS-c and mitochondrial peptides for children.